Skip to content

Diagnostic value of 68Ga pentixafor PET / CT adrenal imaging in the diagnose and typing of primary aldosteronism

Diagnostic value of 68Ga pentixafor PET / CT adrenal imaging in the diagnose and typing of primary aldosteronism

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073049
Enrollment
Unknown
Registered
2023-06-30
Start date
2022-08-31
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary aldosteronism

Interventions

Gold Standard:the composite result of adrenal vein sampling and pathology

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria can be enrolled: 1) > 18 years old, regardless of gender; 2) Primary aldosteronism was definitely diagnosed by plasma aldosterone to renin ratio (ARR) and at least one diagnostic test (fludrocortisone test, oral sodium loading test, saline infusion test and captopril test); 3) Patients who plan to receive AVS for typing of PA; 4) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: Patients with any of the following conditions cannot be enrolled in this study: 1)Patients with severe hepatic and renal dysfunction or other serious clinical diseases, which affect the normal diagnosis and treatment of primary aldosteronism. 2)Patients who are lactating, pregnant or think they may be pregnant or preparing for pregnancy.

Design outcomes

Primary

MeasureTime frame
68Ga-pentixafor PET/CT;accuracy;

Secondary

MeasureTime frame
adrenal vein sampling(AVS);pathology;sensibility;specificity;

Countries

China

Contacts

Public ContactWei Ma

Peking University First Hospital

kmmawei@sina.com+86 136 8105 0902

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026